[	0	1	O
Inhibitory	1	11	O
effect	12	18	O
of	19	21	O
adenovirus	22	32	B-Organism
-	32	33	O
mediated	33	41	O
endostatin	42	52	B-Gene_or_gene_product
gene	53	57	O
transfer	58	66	O
on	67	69	O
transplanted	70	82	O
lung	83	87	B-Pathological_formation
carcinoma	88	97	I-Pathological_formation
in	98	100	O
mice	101	105	B-Organism
]	105	106	O

OBJECTIVE	108	117	O
:	117	118	O
To	119	121	O
investigate	122	133	O
the	134	137	O
effect	138	144	O
of	145	147	O
adenovirus	148	158	B-Organism
-	158	159	O
mediated	159	167	O
endostatin	168	178	B-Gene_or_gene_product
gene	179	183	O
transfer	184	192	O
on	193	195	O
transplanted	196	208	O
lung	209	213	B-Pathological_formation
cancer	214	220	I-Pathological_formation
in	221	223	O
mice	224	228	B-Organism
and	229	232	O
its	233	236	O
mechanism	237	246	O
of	247	249	O
action	250	256	O
.	256	257	O

METHODS	258	265	O
:	265	266	O
Transplant	267	277	O
tumor	278	283	B-Pathological_formation
model	284	289	O
was	290	293	O
induced	294	301	O
by	302	304	O
subcutaneous	305	317	O
inoculation	318	329	O
of	330	332	O
2	333	334	O
x	335	336	O
10	337	339	O
(	339	340	O
6	340	341	O
)	341	342	O
Lewis	343	348	B-Cell
lung	349	353	I-Cell
cancer	354	360	I-Cell
(	361	362	I-Cell
LLC	362	365	I-Cell
)	365	366	I-Cell
cells	367	372	I-Cell
into	373	377	O
the	378	381	O
back	382	386	O
of	387	389	O
C57BL	390	395	O
/	395	396	O
6	396	397	O
mice	398	402	B-Organism
.	402	403	O

The	404	407	O
mice	408	412	B-Organism
were	413	417	O
treated	418	425	O
by	426	428	O
intratumoral	429	441	O
injection	442	451	O
of	452	454	O
2	455	456	O
x	457	458	O
10	459	461	O
(	461	462	O
9	462	463	O
)	463	464	O
pfu	465	468	O
Ad	469	471	B-Gene_or_gene_product
-	471	472	I-Gene_or_gene_product
mEndostatin	472	483	I-Gene_or_gene_product
.	483	484	O

The	485	488	O
expression	489	499	O
of	500	502	O
endostatin	503	513	B-Gene_or_gene_product
in	514	516	O
situ	517	521	O
and	522	525	O
its	526	529	O
maintaining	530	541	O
time	542	546	O
were	547	551	O
detected	552	560	O
by	561	563	O
immunohistochemistry	564	584	O
and	585	588	O
Western	589	596	O
Blot	597	601	O
,	601	602	O
respectively	603	615	O
.	615	616	O

The	617	620	O
endostatin	621	631	B-Gene_or_gene_product
level	632	637	O
in	638	640	O
serum	641	646	B-Organism_substance
was	647	650	O
determined	651	661	O
by	662	664	O
ELISA	665	670	O
.	671	672	O

The	673	676	O
inhibition	677	687	O
of	688	690	O
tumor	691	696	B-Pathological_formation
growth	697	703	O
and	704	707	O
changes	708	715	O
of	716	718	O
survival	719	727	O
were	728	732	O
recorded	733	741	O
and	742	745	O
the	746	749	O
microvessel	750	761	B-Tissue
density	762	769	O
(	770	771	O
MVD	771	774	O
)	774	775	O
was	776	779	O
determined	780	790	O
by	791	793	O
histochemical	794	807	O
stainingwith	808	820	O
CD31	821	825	B-Gene_or_gene_product
and	826	829	O
CD105	830	835	B-Gene_or_gene_product
antibodies	836	846	O
.	846	847	O

The	848	851	O
tumor	852	857	B-Pathological_formation
apoptosis	858	867	O
was	868	871	O
observed	872	880	O
by	881	883	O
electron	884	892	O
microscopy	893	903	O
.	903	904	O

RESULTS	905	912	O
:	912	913	O
In	914	916	O
comparison	917	927	O
with	928	932	O
controls	933	941	O
,	941	942	O
intratumoral	943	955	O
injection	956	965	O
of	966	968	O
Ad	969	971	B-Gene_or_gene_product
-	971	972	I-Gene_or_gene_product
mEndostatin	972	983	I-Gene_or_gene_product
significantly	984	997	O
inhibited	998	1007	O
the	1008	1011	O
tumor	1012	1017	B-Pathological_formation
growth	1018	1024	O
and	1025	1028	O
metastasis	1029	1039	O
,	1039	1040	O
and	1041	1044	O
prolonged	1045	1054	O
the	1055	1058	O
survival	1059	1067	O
rate	1068	1072	O
of	1073	1075	O
mice	1076	1080	B-Organism
(	1081	1082	O
P	1082	1083	O
less	1085	1089	O
than	1090	1094	O
0	1096	1097	O
.	1097	1098	O
05	1098	1100	O
)	1100	1101	O
.	1101	1102	O

Strong	1103	1109	O
positive	1110	1118	O
expression	1119	1129	O
of	1130	1132	O
mEndostatin	1133	1144	B-Gene_or_gene_product
was	1145	1148	O
seen	1149	1153	O
in	1154	1156	O
the	1157	1160	O
tumor	1161	1166	B-Tissue
tissue	1167	1173	I-Tissue
after	1174	1179	O
injection	1180	1189	O
of	1190	1192	O
Ad	1193	1195	B-Gene_or_gene_product
-	1195	1196	I-Gene_or_gene_product
mEndostatin	1196	1207	I-Gene_or_gene_product
,	1207	1208	O
immunhistochemically	1209	1229	O
ostained	1230	1238	O
by	1239	1241	O
mouse	1242	1247	B-Organism
endostatin	1248	1258	B-Gene_or_gene_product
monoclonal	1259	1269	O
antibody	1270	1278	O
,	1278	1279	O
while	1280	1285	O
the	1286	1289	O
control	1290	1297	O
groups	1298	1304	O
showed	1305	1311	O
only	1312	1316	O
very	1317	1321	O
low	1322	1325	O
expression	1326	1336	O
or	1337	1339	O
absence	1340	1347	O
.	1347	1348	O

Serum	1349	1354	O
endostatin	1355	1365	B-Gene_or_gene_product
concentration	1366	1379	O
was	1380	1383	O
1540	1384	1388	O
+	1389	1390	O
/	1390	1391	O
-	1391	1392	O
560	1393	1396	O
ng	1397	1399	O
/	1399	1400	O
ml	1400	1402	O
at	1403	1405	O
the	1406	1409	O
second	1410	1416	O
week	1417	1421	O
of	1422	1424	O
administration	1425	1439	O
,	1439	1440	O
the	1441	1444	O
expression	1445	1455	O
of	1456	1458	O
endostatin	1459	1469	B-Gene_or_gene_product
diminished	1470	1480	O
a	1481	1482	O
month	1483	1488	O
later	1489	1494	O
.	1494	1495	O

The	1496	1499	O
microvessel	1500	1511	B-Tissue
density	1512	1519	O
(	1520	1521	O
MVD	1521	1524	O
)	1524	1525	O
)	1525	1526	O
decreased	1527	1536	O
from	1537	1541	O
42	1542	1544	O
.	1544	1545	O
4	1545	1546	O
+	1547	1548	O
/	1548	1549	O
-	1549	1550	O
4	1551	1552	O
.	1552	1553	O
8	1553	1554	O
to	1555	1557	O
10	1558	1560	O
.	1560	1561	O
5	1561	1562	O
+	1563	1564	O
/	1564	1565	O
-	1565	1566	O
3	1567	1568	O
.	1568	1569	O
2	1569	1570	O
per	1571	1574	O
x	1575	1576	O
200	1577	1580	O
magnificetion	1581	1594	O
microscopic	1595	1606	O
field	1607	1612	O
by	1613	1615	O
CD10	1616	1620	B-Gene_or_gene_product
staining	1621	1629	O
and	1630	1633	O
from	1634	1638	O
68	1639	1641	O
.	1641	1642	O
5	1642	1643	O
+	1644	1645	O
/	1645	1646	O
-	1646	1647	O
4	1648	1649	O
.	1649	1650	O
5	1650	1651	O
to	1652	1654	O
37	1655	1657	O
.	1657	1658	O
5	1658	1659	O
+	1660	1661	O
/	1661	1662	O
-	1662	1663	O
4	1664	1665	O
.	1665	1666	O
6	1666	1667	O
by	1668	1670	O
CD31	1671	1675	B-Gene_or_gene_product
staining	1676	1684	O
,	1684	1685	O
respectively	1686	1698	O
(	1699	1700	O
P	1700	1701	O
less	1703	1707	O
than	1708	1712	O
0	1714	1715	O
.	1715	1716	O
05	1716	1718	O
)	1718	1719	O
.	1719	1720	O

More	1721	1725	O
apoptotic	1726	1735	O
tumor	1736	1741	B-Cell
cells	1742	1747	I-Cell
were	1748	1752	O
seen	1753	1757	O
under	1758	1763	O
the	1764	1767	O
transmission	1768	1780	O
electron	1781	1789	O
microscope	1790	1800	O
.	1800	1801	O

CONCLUSION	1802	1812	O
:	1812	1813	O
Endostatin	1814	1824	B-Gene_or_gene_product
gene	1825	1829	O
therapy	1830	1837	O
mediated	1838	1846	O
by	1847	1849	O
adenoviral	1850	1860	O
vector	1861	1867	O
efficiently	1868	1879	O
induces	1880	1887	O
expression	1888	1898	O
of	1899	1901	O
endostatin	1902	1912	B-Gene_or_gene_product
in	1913	1915	O
vivo	1916	1920	O
,	1920	1921	O
and	1922	1925	O
inhibits	1926	1934	O
the	1935	1938	O
growth	1939	1945	O
and	1946	1949	O
metastasis	1950	1960	O
of	1961	1963	O
tumor	1964	1969	B-Pathological_formation
.	1969	1970	O

It	1971	1973	O
is	1974	1976	O
concluded	1977	1986	O
that	1987	1991	O
its	1992	1995	O
action	1996	2002	O
is	2003	2005	O
targeted	2006	2014	O
to	2015	2017	O
tumor	2018	2023	B-Multi-tissue_structure
neovasculature	2024	2038	I-Multi-tissue_structure
and	2039	2042	O
the	2043	2046	O
mechanism	2047	2056	O
is	2057	2059	O
inhibition	2060	2070	O
of	2071	2073	O
tumor	2074	2079	B-Pathological_formation
angiogenesis	2080	2092	O
.	2092	2093	O

